83.78 USD
-0.56 (-0.66%)
83.78 USD
0 (0%)
Overall LMAT gets a fundamental rating of 7 out of 10. We evaluated LMAT against 185 industry peers in the Health Care Equipment & Supplies industry. LMAT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. LMAT is not valued too expensively and it also shows a decent growth rate. With these ratings, LMAT could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year LMAT was profitable.
In the past year LMAT had a positive cash flow from operations.
In the past 5 years LMAT has always been profitable.
Each year in the past 5 years LMAT had a positive operating cash flow.
1.2 Ratios
LMAT's Return On Assets of 8.92% is amongst the best of the industry. LMAT outperforms 91.35% of its industry peers.
With an excellent Return On Equity value of 14.08%, LMAT belongs to the best of the industry, outperforming 90.27% of the companies in the same industry.
LMAT has a better Return On Invested Capital (8.43%) than 87.03% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LMAT is in line with the industry average of 8.82%.
The 3 year average ROIC (8.26%) for LMAT is below the current ROIC(8.43%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROIC | 8.43% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
LMAT's Profit Margin of 22.14% is amongst the best of the industry. LMAT outperforms 94.05% of its industry peers.
LMAT's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 25.71%, LMAT belongs to the top of the industry, outperforming 95.14% of the companies in the same industry.
LMAT's Operating Margin has improved in the last couple of years.
LMAT's Gross Margin of 70.97% is fine compared to the rest of the industry. LMAT outperforms 78.92% of its industry peers.
LMAT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LMAT is destroying value.
LMAT has more shares outstanding than it did 1 year ago.
LMAT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LMAT has a worse debt to assets ratio.
2.2 Solvency
LMAT has an Altman-Z score of 7.23. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.23, LMAT belongs to the top of the industry, outperforming 84.86% of the companies in the same industry.
The Debt to FCF ratio of LMAT is 2.54, which is a good value as it means it would take LMAT, 2.54 years of fcf income to pay off all of its debts.
LMAT's Debt to FCF ratio of 2.54 is amongst the best of the industry. LMAT outperforms 84.86% of its industry peers.
LMAT has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.44, LMAT is in line with its industry, outperforming 45.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Altman-Z | 7.23 |
ROIC/WACC0.98
WACC8.58%
2.3 Liquidity
LMAT has a Current Ratio of 13.58. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
LMAT's Current ratio of 13.58 is amongst the best of the industry. LMAT outperforms 97.84% of its industry peers.
A Quick Ratio of 11.45 indicates that LMAT has no problem at all paying its short term obligations.
The Quick ratio of LMAT (11.45) is better than 95.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 19.67% over the past year.
The Earnings Per Share has been growing by 17.13% on average over the past years. This is quite good.
Looking at the last year, LMAT shows a quite strong growth in Revenue. The Revenue has grown by 13.07% in the last year.
LMAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.41% yearly.
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
3.2 Future
Based on estimates for the next years, LMAT will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.10% on average per year.
Based on estimates for the next years, LMAT will show a quite strong growth in Revenue. The Revenue will grow by 9.65% on average per year.
EPS Next Y27.73%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 38.26, LMAT can be considered very expensive at the moment.
LMAT's Price/Earnings ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 70.27% of the companies in the same industry.
LMAT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.57.
A Price/Forward Earnings ratio of 31.75 indicates a quite expensive valuation of LMAT.
71.35% of the companies in the same industry are more expensive than LMAT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, LMAT is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.26 | ||
| Fwd PE | 31.75 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LMAT is valued a bit cheaper than 76.76% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LMAT is valued a bit cheaper than the industry average as 79.46% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.7 | ||
| EV/EBITDA | 19.68 |
4.3 Compensation for Growth
LMAT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of LMAT may justify a higher PE ratio.
A more expensive valuation may be justified as LMAT's earnings are expected to grow with 14.06% in the coming years.
PEG (NY)1.38
PEG (5Y)2.23
EPS Next 2Y16.63%
EPS Next 3Y14.06%
5. Dividend
5.1 Amount
With a yearly dividend of 0.94%, LMAT is not a good candidate for dividend investing.
LMAT's Dividend Yield is rather good when compared to the industry average which is at 0.20. LMAT pays more dividend than 91.89% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.88, LMAT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.94% |
5.2 History
On average, the dividend of LMAT grows each year by 13.60%, which is quite nice.
LMAT has paid a dividend for at least 10 years, which is a reliable track record.
LMAT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
32.20% of the earnings are spent on dividend by LMAT. This is a low number and sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP32.2%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
83.78
-0.56 (-0.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.15%
Inst Owner Change-3.91%
Ins Owners7.89%
Ins Owner Change-4.67%
Market Cap1.90B
Revenue(TTM)240.87M
Net Income(TTM)53.34M
Analysts78.82
Price TargetN/A
Short Float %5.19%
Short Ratio6.81
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.94% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP32.2%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.59%
Min EPS beat(2)3.81%
Max EPS beat(2)7.38%
EPS beat(4)2
Avg EPS beat(4)0.79%
Min EPS beat(4)-5.52%
Max EPS beat(4)7.38%
EPS beat(8)6
Avg EPS beat(8)4.68%
EPS beat(12)9
Avg EPS beat(12)4.66%
EPS beat(16)9
Avg EPS beat(16)-0.71%
Revenue beat(2)1
Avg Revenue beat(2)-1.47%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.49%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)-0.28%
PT rev (3m)-0.42%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)4.07%
EPS NY rev (1m)6.5%
EPS NY rev (3m)6.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.16%
Revenue NY rev (1m)-0.94%
Revenue NY rev (3m)-0.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.26 | ||
| Fwd PE | 31.75 | ||
| P/S | 7.89 | ||
| P/FCF | 28.7 | ||
| P/OCF | 25.94 | ||
| P/B | 5.02 | ||
| P/tB | 6.76 | ||
| EV/EBITDA | 19.68 |
EPS(TTM)2.19
EY2.61%
EPS(NY)2.64
Fwd EY3.15%
FCF(TTM)2.92
FCFY3.48%
OCF(TTM)3.23
OCFY3.85%
SpS10.62
BVpS16.7
TBVpS12.4
PEG (NY)1.38
PEG (5Y)2.23
Graham Number28.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROCE | 10.97% | ||
| ROIC | 8.43% | ||
| ROICexc | 21.47% | ||
| ROICexgc | 38.36% | ||
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% | ||
| FCFM | 27.5% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexgc growth 3Y-0.4%
ROICexgc growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 68.51% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.46% | ||
| Profit Quality | 124.17% | ||
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 | ||
| Altman-Z | 7.23 |
F-Score5
WACC8.58%
ROIC/WACC0.98
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
EPS Next Y27.73%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
EBIT growth 1Y24.85%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year45.26%
EBIT Next 3Y22.27%
EBIT Next 5YN/A
FCF growth 1Y189.96%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y143.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%
LEMAITRE VASCULAR INC / LMAT FAQ
What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a fundamental rating of 7 / 10 to LMAT.
Can you provide the valuation status for LEMAITRE VASCULAR INC?
ChartMill assigns a valuation rating of 4 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.
How profitable is LEMAITRE VASCULAR INC (LMAT) stock?
LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 9 / 10.
What is the valuation of LEMAITRE VASCULAR INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LEMAITRE VASCULAR INC (LMAT) is 38.26 and the Price/Book (PB) ratio is 5.02.
What is the expected EPS growth for LEMAITRE VASCULAR INC (LMAT) stock?
The Earnings per Share (EPS) of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 27.73% in the next year.